HIV SeropositivityHIV SeroprevalenceHIV InfectionsSubstance Abuse, IntravenousSexual BehaviorRisk FactorsSeroepidemiologic StudiesAntibodies, ViralCross-Sectional StudiesAntibodies, BacterialChlamydophila pneumoniaeImmunoglobulin GChlamydophila InfectionsQuestionnairesSerologic TestsHIV SeronegativityEnzyme-Linked Immunosorbent AssayPrevalenceCohort StudiesUnited StatesAge FactorsProspective StudiesHelicobacter pyloriHelicobacter InfectionsCase-Control StudiesRural PopulationAcquired Immunodeficiency SyndromeToxocariasisIncidenceAntibodies, ProtozoanLogistic ModelsOdds RatioAIDS SerodiagnosisHIV-1Follow-Up StudiesCytomegalovirus InfectionsLongitudinal StudiesSex FactorsRisk-TakingHerpesvirus 2, HumanTime FactorsToxoplasmosisHepatitis CDisabled PersonsBlood DonorsToxocaraHealth Knowledge, Attitudes, PracticeMultivariate AnalysisHomosexuality, MaleBrazilUrban PopulationSexual PartnersPapillomavirus InfectionsAge DistributionSyphilisHerpes GenitalisCD4 Lymphocyte CountAnti-HIV AgentsNeosporaRegression AnalysisMass ScreeningTreatment OutcomeCytomegalovirusImmunoglobulin AHomosexualityIndiaToxoplasmaInterviews as TopicHepatitis BImmunoglobulin MPregnancyAntibodies, HelminthHepatitis A Virus, HumanChinaUgandaZimbabweHuman papillomavirus 16